LMR Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

LMR Partners’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-332,223	Closed	-$5.47M	–	1386
2023 Q4	$5.47M	Buy	+332,223	New	+$5.23M	0.06%	288

LMR Partners's ORTX Position: Q1 2024 in Review

LMR Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 332,223 shares — an estimated $5.47M sold.

LMR Partners first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $5.47M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

LMR Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 332,223 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $5.47M.
LMR Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
LMR Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $5.47M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.